60 Degrees Pharmaceuticals- Warrants (16/05/2028) Operating Income

The latest operating income for SXTPW is $-8.6M as of June 2026. That compares with $-7.7M in the prior-year period — down 11.7% year over year. Investors often review this figure alongside 60 Degrees Pharmaceuticals- Warrants (16/05/2028)'s historical trend and sector peers before judging valuation or financial health.

Over the past year, SXTPW's operating income moved from $-7.7M to $-8.6M — a 11.7% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in 60 Degrees Pharmaceuticals- Warrants (16/05/2028)'s operating scale or balance-sheet position.

A operating income figure of $-8.6M for SXTPW is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting SXTPW's operating income ($-8.6M), review year-over-year change from $-7.7M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.